@midwit_capital Avatar @midwit_capital MidCurveCapital

MidCurveCapital posts on X about $psnl, $gtlb, $tem, $ntra the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 48.46% finance 19.23% technology brands 3.85% financial services 3.85% cryptocurrencies 3.08% currencies 0.77% countries 0.77%

Social topic influence $psnl #42, $gtlb #1, $tem 8.46%, $ntra #16, ai 8.46%, short interest 6.15%, end of 5.38%, stocks 4.62%, $arkg 4.62%, ceo 3.85%

Top accounts mentioned or mentioned by @bk8374021732854 @outerbridgecap @goldmansachs @dibhassen @alexeimartov @vrntperception @claudeai @maplefinance @marketcomacc @foresightdx @thdxr @anthropicai @jonchu @rjccapital @techfund1 @rwang07 @onodacapital @viggykrishnan @thestalwart @benthompson

Top assets mentioned GitLab Inc. (GTLB) Tempus AI, Inc. (TEM) Natera, Inc. Common Stock (NTRA) Prime Medicine, Inc. (PRME) Syrup (SYRUP) Goldman Sachs (GS) Monte Rosa Therapeutics, Inc. (GLUE) Twist Bioscience Corporation Common Stock (TWST) ARK Innovation ETF (ARKK) Sable Offshore Corp. (SOC) Morgan Stanley (MS) Iris Energy Limited (IREN) Hut [--] Mining Corp. (HUT) MARA Holdings, Inc. (MARA) Bitcoin (BTC) Cloudflare, Inc. (NET) Datadog Inc (DDOG)

Top Social Posts

Top posts by engagements in the last [--] hours

"🫡 this guy is outperforming every single hedge fund in existence https://t.co/0YCCcd4BcA this guy is outperforming every single hedge fund in existence https://t.co/0YCCcd4BcA"
X Link 2024-10-27T14:10Z [----] followers, 14.7K engagements

"I wont even bother doing some math here. Yall arent ready for it. $GTLB"
X Link 2026-02-09T09:10Z [----] followers, 10.9K engagements

"I hate when that happens. $GLUE $GLUE 6-8 months ago you could buy this at $4-5 at negative EV. Now they offering $300m @ $24. Asymmetrical value at its finest. These moments are rare but golden. $GLUE 6-8 months ago you could buy this at $4-5 at negative EV. Now they offering $300m @ $24. Asymmetrical value at its finest. These moments are rare but golden"
X Link 2026-01-10T17:25Z [----] followers, [----] engagements

"Huge milestone for $PSNL. https://investors.personalis.com/news-releases/news-release-details/personalis-receives-medicare-coverage-next-personalr-lung-cancer https://investors.personalis.com/news-releases/news-release-details/personalis-receives-medicare-coverage-next-personalr-lung-cancer"
X Link 2026-02-10T11:35Z [----] followers, [----] engagements

"The repository is key to context management. Sounds a lot like $GTLB's knowledge graph"
X Link 2026-02-13T14:28Z [----] followers, [---] engagements

"$PSNL now officially a Penny Stock. Rekt"
X Link 2023-10-20T15:02Z [----] followers, [----] engagements

"Morgan Stanley owns (Q2 filings): 2.26% of $IREN / 1.91% of $HUT / 1.9% of $MARA Morgan Stanley's Global Head of Research is Pitching #Bitcoin Mining Stocks to CIOs 👍 https://t.co/cVcRWdPfKJ Morgan Stanley's Global Head of Research is Pitching #Bitcoin Mining Stocks to CIOs 👍 https://t.co/cVcRWdPfKJ"
X Link 2024-10-27T10:44Z [----] followers, [----] engagements

"With NeXT Personal Dx volume reaching [----] in Q2 [----] $PSNL is now operating at approximately 1.9% of $NTRA's Signatera volume. I expect this ratio to accelerate meaningfully once reimbursement is secured and $TEM can go full throttle on sales"
X Link 2025-08-08T08:00Z [----] followers, [----] engagements

"$NTRA went from "ultrasensitive is marketing fluff with 2017-tier Signatera sensitivity" to "actually we desperately need an ultrasensitive assay" at remarkable speed. Today Natera announced the acquisition of @ForesightDx a leader in ultrasensitive MRD detection. This combination brings together Foresights phased variant technology with Nateras Signatera platform to further strengthen performance across both solid tumors and hematologic https://t.co/0HelFaWAN4 Today Natera announced the acquisition of @ForesightDx a leader in ultrasensitive MRD detection. This combination brings together"
X Link 2025-12-05T12:44Z [----] followers, [----] engagements

"One year ago today. Quite the year for $GLUE. $GLUE now trading below 💰 in the 🏦. Exactly my jam. Added more at $5.5. $GLUE now trading below 💰 in the 🏦. Exactly my jam. Added more at $5.5"
X Link 2026-01-10T17:36Z [----] followers, [----] engagements

"T. Rowe Price took a 12% stake in $PSNL. They absorbed the ATM. Fantastic news"
X Link 2026-01-15T20:00Z [----] followers, [----] engagements

"All of this is rather fascinating. $GTLB OpenCode can now officially be used with your GitLab Duo subscription all claude models (sonnet opus and haiku) are available enjoy https://t.co/CsAtrwCu4x OpenCode can now officially be used with your GitLab Duo subscription all claude models (sonnet opus and haiku) are available enjoy https://t.co/CsAtrwCu4x"
X Link 2026-01-20T13:39Z [----] followers, 18K engagements

"Sometimes things are complicated. This isnt one of those times. $TWST This will be a large company This will be a large company"
X Link 2026-01-24T21:32Z [----] followers, 11.2K engagements

"The bell I'm ringing at the bottom: $GTLB Software has never been more bombed out https://t.co/eGCw5aTDKa Software has never been more bombed out https://t.co/eGCw5aTDKa"
X Link 2026-01-27T08:42Z [----] followers, [----] engagements

"$NET being an AI winner was obvious to anyone paying attention for years now. $GTLB being an obvious AI winner is clear today. Today about 70% of all AI companies traffic is behind Cloudflare. $NET https://t.co/GV2Gx7HvHS Today about 70% of all AI companies traffic is behind Cloudflare. $NET https://t.co/GV2Gx7HvHS"
X Link 2026-01-27T16:00Z [----] followers, 24.3K engagements

"$GTLB bull case right here: @thdxr From vibe coding to vibe devops-ing @thdxr From vibe coding to vibe devops-ing"
X Link 2026-01-30T15:29Z [----] followers, [----] engagements

"$GTLB DAP GA: First one on the house. That feeling when your GitHub Copilot premium requests run out😭 I've had access to this thing for two weeks and I'm absolutely mind blown at what I've been able to do with it. It has easily 10X my performance if not more. https://t.co/sdAl9BbuXD That feeling when your GitHub Copilot premium requests run out😭 I've had access to this thing for two weeks and I'm absolutely mind blown at what I've been able to do with it. It has easily 10X my performance if not more. https://t.co/sdAl9BbuXD"
X Link 2026-01-31T09:48Z [----] followers, [----] engagements

"Added $GTLB today - $36"
X Link 2026-02-02T18:23Z [----] followers, [----] engagements

"To use Codex app full capabilities (working directly with repos automating tasks integrating into dev workflows) you must connect a GitHub account. For @AnthropicAI and the likes $GTLB is a strategic asset. Introducing the Codex appa powerful command center for building with agents. Now available on macOS. https://t.co/HW05s2C9Nr Introducing the Codex appa powerful command center for building with agents. Now available on macOS. https://t.co/HW05s2C9Nr"
X Link 2026-02-03T08:29Z [----] followers, [----] engagements

"Added more $GTLB - $32.5. Price action is offensive. Added $GTLB today - $36. https://t.co/TMjrVGeMex Added $GTLB today - $36. https://t.co/TMjrVGeMex"
X Link 2026-02-03T17:28Z [----] followers, [----] engagements

"Guess whos buying the dip Far from capitulating. Just getting started. $GTLB Absolute capitulation vibes in anything SaaS and payment infrastructure. A true bloodbath. Absolute capitulation vibes in anything SaaS and payment infrastructure. A true bloodbath"
X Link 2026-02-03T17:58Z [----] followers, [----] engagements

"Both tails buying $GTLB today.🤝 @jonchu Or you buy a bunch of great SaaS cos at 2-4x arr today. Bought some $gtlb @jonchu Or you buy a bunch of great SaaS cos at 2-4x arr today. Bought some $gtlb"
X Link 2026-02-03T20:45Z [----] followers, [----] engagements

"Little blast from the past. Today $GTLB is closer to 4x forward sales which seems low. IDK but good chance we are at the opposite extreme today. $GTLB at $115 looks like it's trading above 40x forward sales That seems high. Anyone know the bull thesis from here And why would you pick Gitlab over GitHub They seem pretty similar to me. $GTLB at $115 looks like it's trading above 40x forward sales That seems high. Anyone know the bull thesis from here And why would you pick Gitlab over GitHub They seem pretty similar to me"
X Link 2026-02-03T21:46Z [----] followers, [----] engagements

"$GTLB Duo vs. Claude Code:"
X Link 2026-02-04T18:26Z [----] followers, [----] engagements

"Are you still giga long $GTLB 4% of GitHub public commits are being authored by Claude Code right now. At the current trajectory we believe that Claude Code will be 20%+ of all daily commits by the end of [----]. While you blinked AI consumed all of software development. Read more 👇 https://t.co/HzK4nbe2vy https://t.co/E1kIjfrNgk 4% of GitHub public commits are being authored by Claude Code right now. At the current trajectory we believe that Claude Code will be 20%+ of all daily commits by the end of [----]. While you blinked AI consumed all of software development. Read more 👇"
X Link 2026-02-06T09:23Z [----] followers, 13.3K engagements

"Ding Dong. $GTLB The bell I'm ringing at the bottom: $GTLB https://t.co/Em0A3WF6Ue The bell I'm ringing at the bottom: $GTLB https://t.co/Em0A3WF6Ue"
X Link 2026-02-06T13:35Z [----] followers, [----] engagements

"@RJCcapital Worth taking a closer look at Pure Storage imo"
X Link 2026-02-06T14:55Z [----] followers, [----] engagements

"@outerbridgecap Read"
X Link 2026-02-06T16:39Z [----] followers, [----] engagements

"The Bull Case for Software from @techfund1 is a great read. I think this is where the narrative moves next & its perfectly aligned with why Im bullish $GTLB. Are you really going to go through the pain of migrating off your existing repo CI/CD and security workflows to save a few bucks or just layer AI on top of what you already use Meanwhile: $GTLB fundamentals remain solid AI monetization is just beginning & growth could re-accelerate. Once the market realizes this is a stickier platform business than currently priced the stock (just like the narrative) will enter a new regime. 4/ When"
X Link 2026-02-08T11:10Z [----] followers, 20.6K engagements

"$GTLB CEO did. Not a SINGLE CEO of a major SAAS corp has bought stock in their company even after all this bloodbath. Yet the monkeys are trying to call the low in SAAS every single day. Bless 🥹🙏 Not a SINGLE CEO of a major SAAS corp has bought stock in their company even after all this bloodbath. Yet the monkeys are trying to call the low in SAAS every single day. Bless 🥹🙏"
X Link 2026-02-09T07:59Z [----] followers, 11.1K engagements

"Scooped up some $GTLB calls pre market at $30.8"
X Link 2026-02-09T14:29Z [----] followers, [----] engagements

"AI finally disrupted GitHub - via server load not by displacement.🙃 Time to re-rate $GTLB"
X Link 2026-02-09T17:10Z [----] followers, [----] engagements

"$GTLB I guess its time to move our org to a self-hosted GitLab I guess its time to move our org to a self-hosted GitLab"
X Link 2026-02-09T19:28Z [----] followers, [----] engagements

"Im assembling a team. $GTLB It turns out ppl who understand software better (Anthropic for instance) are speaking with their wallets And the message is quite different than what you hear from armchair "software specialists". $DDOG https://t.co/wYGWlyvuE8 It turns out ppl who understand software better (Anthropic for instance) are speaking with their wallets And the message is quite different than what you hear from armchair "software specialists". $DDOG https://t.co/wYGWlyvuE8"
X Link 2026-02-11T12:11Z [----] followers, [----] engagements

"The truck I'm backing up at $30 $GTLB: Claude commits 4% of GitHub estimated to reach 20% of commits by the end [----]. Claude fully enclosed in GitLab while transitioning to a usage based model with Duo platform. Market is so short term. Buying leaps in $GLTB today. 4x EV/sales 1B in cash co-founder with 10% https://t.co/a8bnOHrguE Claude commits 4% of GitHub estimated to reach 20% of commits by the end [----]. Claude fully enclosed in GitLab while transitioning to a usage based model with Duo platform. Market is so short term. Buying leaps in $GLTB today. 4x EV/sales 1B in cash co-founder with"
X Link 2026-02-11T20:18Z [----] followers, [----] engagements

"@BK8374021732854 No hard feelings. That's what makes a market. I own the stock since few month. $34 cost base. Let's see what happens. :)"
X Link 2026-02-11T21:35Z [----] followers, [---] engagements

"$GTLB multiple is at a historically low level which by itself isnt enough reason to buy the stock but it does create an attractive entry point. Q4/25 is a wildcard but I don't want to miss the train. We may start to get green shoots in Q1/26 as DUO beta users convert into paying customers. The real catalyst however will be revenue acceleration by participation in AI and by Q2/26 we could begin to see this materialize in a meaningful way as customers deploy AI agents that are currently in early development. Close to a 1Milly position here and ready to FAFO."
X Link 2026-02-11T22:04Z [----] followers, [---] engagements

"@rwang07 Any indication that meta was driving this"
X Link 2026-02-12T08:54Z [----] followers, [---] engagements

"$GTLB: Workflows / Context / Guardrails"
X Link 2026-02-13T12:37Z [----] followers, [----] engagements

"Uncle Bill with the latest: https://www.youtube.com/watchv=UcioyqXIy8c https://www.youtube.com/watchv=UcioyqXIy8c"
X Link 2026-02-13T12:43Z [----] followers, [---] engagements

"Do you think $GTLB will be more or less relevant in the world outlined in here https://openai.com/index/harness-engineering/ https://openai.com/index/harness-engineering/"
X Link 2026-02-13T14:24Z [----] followers, [----] engagements

"@OnodaCapital @viggy_krishnan @TheStalwart @benthompson Rust Belt trauma was real but largely contained to insulated communities without amplification. In contrast the SaaS boys on the everything app for the next few years:"
X Link 2026-02-13T21:07Z [----] followers, [--] engagements

"@ALEXEIMARTOV @BK8374021732854 https://gitlab.com/gitlab-org/gitlab/-/blob/master/spec/models/user_spec.rb https://gitlab.com/gitlab-org/gitlab/-/blob/master/spec/models/user_spec.rb"
X Link 2026-02-13T21:55Z [----] followers, [---] engagements

"@Banana_Oncology Per their partnership agreement TEM can buy 19.99% max. MRK has right of first refusal. They issued shares via ATM so TEM was able to buy more without hitting the threshold"
X Link 2026-02-13T23:59Z [----] followers, [---] engagements

"@qthomp I'd recommend to sprinkle over some $GTLB"
X Link 2026-02-04T18:12Z [----] followers, [---] engagements

"@VrntPerception Throwing my hat in the ring for $GTLB. Across highly regulated compliance- and security-centric organizations GitLab is well positioned to become a primary gateway for enterprise AI adoption"
X Link 2026-02-05T12:52Z [----] followers, [----] engagements

"@PetramcoC @claudeai = vibes / $GTLB = pipes"
X Link 2026-02-06T13:59Z [----] followers, [---] engagements

"https://www.techinvestments.io/p/the-bull-case-for-software-asml-credo https://www.techinvestments.io/p/the-bull-case-for-software-asml-credo"
X Link 2026-02-08T11:11Z [----] followers, [----] engagements

"Oncology MD/Cancer Center medical director's take on $PSNL. The hedge fund crowd will be finding out soon.🙂 @midwit_capital $psnl is superior in every way to $NTRA as an end user. Market will catch up. 500m vs 30b cap. @midwit_capital $psnl is superior in every way to $NTRA as an end user. Market will catch up. 500m vs 30b cap"
X Link 2026-02-10T18:29Z [----] followers, [----] engagements

"$NTRA still the largest position in @stanleydruck's portfolio btw. You're looking for an intern"
X Link 2026-02-10T18:36Z [----] followers, [---] engagements

"Maybe $GTLB wont go out of business after all.🙃 wild how a fast CI/CD pipeline with good test coverage is basically a competitive advantage now wild how a fast CI/CD pipeline with good test coverage is basically a competitive advantage now"
X Link 2026-02-12T12:00Z [----] followers, [----] engagements

"Dunno but during the AI adoption phase this pricing model could actually prove more cost-effective for organizations than purchasing full licenses for everyone. Even after $GTLB takes its cut"
X Link 2026-02-12T21:18Z [----] followers, [----] engagements

"Seats for Agents after all: "Username starting with 'duo-' 'duo_' 'ai-' 'ai_' is reserved for GitLab AI entities. Please choose a different name." $GTLB $GTLB https://t.co/fkOoLcxd50 $GTLB https://t.co/fkOoLcxd50"
X Link 2026-02-13T21:59Z [----] followers, [----] engagements

"Listen to the engines hum. $GTLB https://open.spotify.com/episode/1fQeakqRH3wJzdhyLinoJ4si=Q0qfg05DTqy_UL4qj2IODg https://open.spotify.com/episode/1fQeakqRH3wJzdhyLinoJ4si=Q0qfg05DTqy_UL4qj2IODg"
X Link 2026-02-14T22:25Z [----] followers, [----] engagements

"Giving an idea of the surface area $GTLB can address with its Agent Platform. https://about.gitlab.com/gitlab-duo/prompt-library/ https://about.gitlab.com/gitlab-duo/prompt-library/"
X Link 2026-02-14T22:54Z [----] followers, [---] engagements

"@atelicinvest $SIE ❤ $GTLB. Many such cases. https://about.gitlab.com/customers/siemens/trk=public_post_comment-text https://about.gitlab.com/customers/siemens/trk=public_post_comment-text"
X Link 2026-02-15T11:21Z [----] followers, [---] engagements

"Virtually impossible not to be long $PSTG once you know what KV-Cache is"
X Link 2026-02-06T16:24Z [----] followers, 32.6K engagements

"Very much in line with $GTLB commentary on context being their differentiating factor in applying AI to SDLC"
X Link 2026-02-09T14:51Z [----] followers, [----] engagements

"Perfect Sunday reading. SaaS full-spectrum awareness. Another name squarely in the Fortress quadrant is $GTLB: Workflows / Context / Guardrails / Deep integration. They have it all. 1/ Anthropic just dropped @claudeai Cowork and the software sector is having a collective aneurysm. Investors spent a decade valuing "recurring revenue" like it was a physical law. Now they realize most SaaS is just a fancy wrapper for stuff AI does for free. #AI #SaaS 🧵👇 1/ Anthropic just dropped @claudeai Cowork and the software sector is having a collective aneurysm. Investors spent a decade valuing"
X Link 2026-02-15T12:55Z [----] followers, 13.8K engagements

"Its worth noting that $PSNL with [----] NeXT Personal tests performed in a single quarter pre-launch is already operating at over 1% of $NTRA Signatera test volumes. In Q4/24 $PSNL performed [----] molecular tests. At the $3500 per-test ADLT rate set by CMS for $NTRA's Signatera equivalent reimbursement for $PSNL would equate to $5.04M in revenue. 1.) $PSNL has indicated they will throttle test volume until reimbursement is secured. 2.) In Q4/24 $PSNL performed [----] molecular tests. At the $3500 per-test ADLT rate set by CMS for $NTRA's Signatera equivalent reimbursement for $PSNL would equate to"
X Link 2025-01-08T15:07Z [----] followers, [----] engagements

"The cavalry has arrived $PSNL $ORCL Ellison sees AI transforming healthcare -- heres how 👇 $TEM -- Platform Powering Precision Medicine $PSNL Decoding Genomes $RXRX -- AI-Driven Drug Discovery $SDGR -- AI-Driven Drug Design $ABCL -- The AI Hunter for Antibodies https://t.co/SiiT3esdVm $ORCL Ellison sees AI transforming healthcare -- heres how 👇 $TEM -- Platform Powering Precision Medicine $PSNL Decoding Genomes $RXRX -- AI-Driven Drug Discovery $SDGR -- AI-Driven Drug Design $ABCL -- The AI Hunter for Antibodies https://t.co/SiiT3esdVm"
X Link 2025-01-23T14:44Z [----] followers, [----] engagements

"During yesterdays $TEM call @lefkofsky commented on $PSNL MRD tests stating: 'They are in the process of submitting across the board for reimbursement.'"
X Link 2025-02-25T09:51Z [----] followers, [----] engagements

"$PSNL ups '25 cash usage to $75-80M ($47M in '24) to fuel its 'Win in MRD' strategy. Boosting test volume expanding clinical studies and enhancing commercial capabilities. $PSNL is playing to win"
X Link 2025-03-01T11:00Z [----] followers, [----] engagements

"If $NTRA CFO thinks that an ultra-sensitive MRD assay can capture market share maybe you should too. $PSNL"
X Link 2025-03-05T14:55Z [----] followers, [----] engagements

"Craig-Hallum initiated coverage on $PSNL with a $8 price target as they "do see significant opportunity for multiple expansion as investors begin to realize that the company has a viable offering and powerful strategic collaborators to help drive growth.""
X Link 2025-03-17T16:48Z [----] followers, [---] engagements

"For anyone newer to the $PSNL story I recommend listening to the last EC (Q3/22) with $PSNL Founder and former CEO John West. He outlined some of the strategic decisions and design choices around NeXT Personal which have not been discussed much recently. NeXT Personal combines high sensitivity with rich data to guide smarter treatment decisions. Its a differentiated platform and about half of its content is focused on tracking tumor changes not just detecting recurrence. That long-term vision could be a key driver of value going forward"
X Link 2025-04-10T12:11Z [----] followers, [----] engagements

"Great read on the developing MRD space by @AGatlin_IBD. $PSNL getting a lot of air time next to it's larger more mature competitors $NTRA $EXAS & $GH. The Blood Test Revolution: These Companies Are Blazing New Trails In Screening For Cancer https://t.co/RWLlOyRiCc The Blood Test Revolution: These Companies Are Blazing New Trails In Screening For Cancer https://t.co/RWLlOyRiCc"
X Link 2025-04-17T16:38Z [----] followers, [----] engagements

"$PSNL NeXT Personal Dx appears well-positioned to pass the MolDx technical assessment and receive Medicare reimbursement. The test meets most coverage criteria supported by clinical evidence and the companys track record: 1.) Strong alignment with MolDx criteria supported by TRACERx and other data. 2.) Personaliss prior success with NeXT Dx coverage. 3.) The precedent of Signatera and other MRD tests receiving coverage. Potential challenges such as cost-effectiveness and competition are acknowledged but do not appear to be significant barriers given the tests strengths. For now all we can do"
X Link 2025-04-30T12:16Z [----] followers, [---] engagements

"$SYRUP is my horse in this race Credit markets are moving onchain We eventually want to power small business loans home loans car loans uncollateralized loans etc. Many people in the world dont have access to credit. We can make it a more efficient (and global) market onchain. Credit markets are moving onchain We eventually want to power small business loans home loans car loans uncollateralized loans etc. Many people in the world dont have access to credit. We can make it a more efficient (and global) market onchain"
X Link 2025-05-04T07:53Z [----] followers, [----] engagements

"If my models right @maplefinance is approaching breakeven run rate. Even after the 20% buyback. It assumes steady cash burn since Q3/24 (last reported) and that Aprils annualized protocol earnings (0.7368% of TVL) hold. $SYRUP"
X Link 2025-05-06T07:21Z [----] followers, [----] engagements

"$PSNL couldnt have found a better partner than $TEM Today we shared our Q1 [----] results highlights include: - Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of [----] - Quarterly gross profit increased 99.8% year-over-year reaching $155.2 million with continued gross margin improvement in both https://t.co/K9UYQY2zjG Today we shared our Q1 [----] results highlights include: - Revenue increased 75.4% year-over-year to $255.7 million in the first quarter of [----] - Quarterly gross profit increased 99.8% year-over-year reaching $155.2 million with continued gross margin"
X Link 2025-05-06T20:57Z [----] followers, [----] engagements

"H.C. Wainwright has made several adjustments to its financial model. The firm extended its financial projections to the year [----] previously set to [----]. Additionally it projects that $PSNL total revenues will grow from $85.9 million in [----] to $654.2 million by 2032"
X Link 2025-05-07T13:02Z [----] followers, [----] engagements

"$TEM CEO on yesterdays call: We're fortunate that $PSNL platform is really best-in-class in terms of a bunch of those metrics because it's whole genome based instead of whole exome based"
X Link 2025-05-07T14:36Z [----] followers, [----] engagements

"H.C. Wainwright projects $PSNL to capture 12% market share by [----]. At todays avg. P/S of [----] that implies a $4B valuation / $45 Stock. H.C. Wainwright has made several adjustments to its financial model. The firm extended its financial projections to the year [----] previously set to [----]. Additionally it projects that $PSNL total revenues will grow from $85.9 million in [----] to $654.2 million by [----]. H.C. Wainwright has made several adjustments to its financial model. The firm extended its financial projections to the year [----] previously set to [----]. Additionally it projects that $PSNL"
X Link 2025-05-08T13:15Z [----] followers, [----] engagements

"According to my model @maplefinance just crossed the break-even line for the first time $SYRUP If my models right @maplefinance is approaching breakeven run rate. Even after the 20% buyback. It assumes steady cash burn since Q3/24 (last reported) and that Aprils annualized protocol earnings (0.7368% of TVL) hold. $SYRUP https://t.co/6PZTw2fCe0 If my models right @maplefinance is approaching breakeven run rate. Even after the 20% buyback. It assumes steady cash burn since Q3/24 (last reported) and that Aprils annualized protocol earnings (0.7368% of TVL) hold. $SYRUP https://t.co/6PZTw2fCe0"
X Link 2025-05-09T07:42Z [----] followers, [----] engagements

"1.) Overview. Standard BioTools $LAB formerly Fluidigm is a life sciences tools company focused on multi-omics and labtech consolidation. The company was restructured by a team of ex-Danaher executives (including the former CTO of Danaher and Pall) with backing from Casdin and Viking. Their strategy is to acquire under-optimized R&D-heavy platforms and apply operational discipline. In [----] LAB acquired SomaLogic in an all-stock deal. The merger was unpopular with SomaLogic shareholders but strategically gave LAB ownership of SomaScan the most comprehensive scalable proteomics platform on the"
X Link 2025-05-28T11:43Z [----] followers, [----] engagements

"Confirmation of what I had already suspected: Absolutely nobody is paying attention. $TEM $PSNL"
X Link 2025-05-28T15:23Z [----] followers, [----] engagements

"Specialist funds like @AberdeenInv_US Healthcare Investors are starting to pay attention to $PSNL:"
X Link 2025-06-04T14:06Z [----] followers, [----] engagements

"Halfway there. Again. $PSNL $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW"
X Link 2025-06-11T14:50Z [----] followers, [----] engagements

"I can't verify but I believe every word of it. $PSNL"
X Link 2025-06-16T16:43Z [----] followers, [----] engagements

"$PSNL is now just one spot behind $NTRA in the $ARKG portfolio. With $NTRA at a $23B market cap and $PSNL at just $570M thats some audacious portfolio construction. Godspeed Cathie"
X Link 2025-06-17T07:53Z [----] followers, [----] engagements

"I'm a simple man. If one of the most consequential scientists of our time is buying more stock in a company he already owns 15% of I know what to do. $PRME"
X Link 2025-06-19T15:08Z [----] followers, 54.7K engagements

"Great to see $TEM already ramping up their sales efforts for $PSNL xM (NeXT Personal Dx). The growth of MRD testing is staggering and the data presented at #ASCO25 only reinforces its clinical utility. It may now be possible to find cancer in patients months before their recurrence would show up in a scan. That kind of early insight has a real impact - catching and https://t.co/KAV1lx2WHb The growth of MRD testing is staggering and the data presented at #ASCO25 only reinforces its clinical utility. It may now be possible to find cancer in patients months before their recurrence would show up"
X Link 2025-06-25T13:23Z [----] followers, [----] engagements

"$PSNL back in the Russell [----] after it was kicked out in June [----]. Great development Looking forward to see it in the Russell 1000"
X Link 2025-06-27T20:30Z [----] followers, [---] engagements

"If you thought @davidrliu was cool just wait: He got banned from playing blackjack at the MGM for being too good.🐐🐐🐐 I'm a simple man. If one of the most consequential scientists of our time is buying more stock in a company he already owns 15% of I know what to do. $PRME https://t.co/oOmCctlvFr I'm a simple man. If one of the most consequential scientists of our time is buying more stock in a company he already owns 15% of I know what to do. $PRME https://t.co/oOmCctlvFr"
X Link 2025-06-29T10:46Z [----] followers, [---] engagements

"$PSNL shorts have held their ground through mid-June with short interest essentially unchanged since the last print. Meanwhile the stock has gained 30% over that period and added another 9% since. Fridays volume was sufficient to cover their position. Curious to see if they did. Short interest in $PSNL declined only modestly (by 9%) through the end of May while the stock traded flat from mid- to late May. Since then $PSNL has surged 26% likely resulting in mark-to-market losses of approx. $5 million for short sellers this month. https://t.co/Kju72ui5LG Short interest in $PSNL declined only"
X Link 2025-06-30T10:26Z [----] followers, [----] engagements

"Over the past [---] years Ive built a concentrated biotech portfolio now valued at over $1000000. I plan to hold and actively manage it through the coming biotech bull market which I believe is about to ignite. My largest positions are $PSNL / $LAB / $PRME. Cowboys may come and go but the rodeo is forever"
X Link 2025-06-30T12:54Z [----] followers, 12.6K engagements

"Things That Make You Go Hmmmm. $XBI $xbi up to 134% of shares outstanding is short. Nothing to see here at all @SECGov $xbi up to 134% of shares outstanding is short. Nothing to see here at all @SECGov"
X Link 2025-07-01T10:35Z [----] followers, [----] engagements

"Choose your fighter $NTRA $PSNL The other thing that makes me bullish is on ctDNA tests is that they continue to improve. Going from Signatera (16 variants) to ultrasensitive tests (Personalis has [----] variants) meaningfully increases sensitivity. For example the TRACERx study this year showed that The other thing that makes me bullish is on ctDNA tests is that they continue to improve. Going from Signatera (16 variants) to ultrasensitive tests (Personalis has [----] variants) meaningfully increases sensitivity. For example the TRACERx study this year showed that"
X Link 2025-07-07T19:29Z [----] followers, [---] engagements

"Another angle to MRD in which $PSNL assay architecture is structurally superior to $NTRA: $PSNL has developed a patented variant-tracking technology which allows to track and annotate individual variants over the whole evolution of a cancer patients trajectory. Something that Signatera can't easily replicate. https://www.personalis.com/technology/next-generation-ctdna-analytics/variant-tracking/ But perhaps the most exciting part about the future of ctDNA is that increasingly we're looking for the actual information content of ctDNA (genetic mutations) not just whether tumor DNA exists and at"
X Link 2025-07-07T19:39Z [----] followers, [----] engagements

"Feels squeezy out there. $XBI 🍋🍋🍋 Things That Make You Go Hmmmm. $XBI https://t.co/NiFUhHwXEn Things That Make You Go Hmmmm. $XBI https://t.co/NiFUhHwXEn"
X Link 2025-07-09T13:41Z [----] followers, [----] engagements

"$PSNL is expanding it's collaboration with $TEM by adding CRC the largest market for MRD testing"
X Link 2025-07-09T20:05Z [----] followers, [----] engagements

"Got this completely backward at first. Turns out with seemingly everyone and their mother short the Russell [----] $PSNL's short interest surged following its inclusion. By the end of June over [---] million shares were sold short roughly 7% of all outstanding shares. Given $PSNL's tightly held institutional ownership sourcing those shares could become increasingly difficult if short sellers attempt to cover. At least at current prices. What's also telling is that this elevated short interest appears to be largely non-discretionary. It doesnt reflect a company-specific short thesis its simply a"
X Link 2025-07-14T11:55Z [----] followers, [----] engagements

"$PRME short interest increased to 20M shares by end of June. Stocks been moving against them ever since. Good luck unwinding that. Great week to be short 18M $PRME shares Great week to be short 18M $PRME shares"
X Link 2025-07-14T12:18Z [----] followers, [----] engagements

"Initiated a position in $XYZ at $71 per share today. It's one of the few crypto-exposed fintechs still widely hated and notably absent from the recent rally"
X Link 2025-07-18T15:13Z [----] followers, [----] engagements

"For the first time ever $PSNL has overtaken $NTRA in the $ARKG ETF. $NTRA's market capitalization remains over [--] times larger than $PSNL's. $PSNL is now just one spot behind $NTRA in the $ARKG portfolio. With $NTRA at a $23B market cap and $PSNL at just $570M thats some audacious portfolio construction. Godspeed Cathie https://t.co/cYw5WVFGTM $PSNL is now just one spot behind $NTRA in the $ARKG portfolio. With $NTRA at a $23B market cap and $PSNL at just $570M thats some audacious portfolio construction. Godspeed Cathie https://t.co/cYw5WVFGTM"
X Link 2025-07-24T07:33Z [----] followers, [----] engagements

"Initiated a speculative position in $SGMO at $0.55 per share as volume spikes. Efficient delivery is emerging as a key differentiator in gene therapy $SGMO BBB-capsid should be well-positioned. Financing is key"
X Link 2025-07-24T11:49Z [----] followers, [----] engagements

"Adding $SGMO in pre-market at $0.56 per share"
X Link 2025-07-25T11:44Z [----] followers, [----] engagements

"$PSNL lowered guidance is a bummer but nothing thesis challenging. All good dont panic"
X Link 2025-08-05T20:12Z [----] followers, [----] engagements

"Growth of $PSNL's NeXT Personal Dx has been on fire since launch and so was CEO Chris Hall on yesterdays call. If anything the long-term win-in-MRD thesis has strengthened following the latest results"
X Link 2025-08-06T13:48Z [----] followers, [----] engagements

"$TEM delivered strong Q2 results with plenty of bullish commentary on MRD during the call. A strong $TEM ultimately benefits $PSNL as well given that their sales force is likely one of the few in the industry capable of rivaling $NTRA's"
X Link 2025-08-08T15:23Z [----] followers, [---] engagements

"$TEM CEO Lefkofsky on the Q2/25 call: "We expect if you kind of fast forward [--] or [--] years my guess is targeted panels go away largely and people are just doing whole genome and whole transcriptome sequencing." $PSNL is ahead of it's time Could it be that $PSNL is in a position where their ultra-deep-sequencing platform can capture more value from falling DNA sequencing cost than others Most other genomic diagnostics companies have optimized around their highest input to COGS: Sequencing cost. https://t.co/jl7WHthWXy Could it be that $PSNL is in a position where their ultra-deep-sequencing"
X Link 2025-08-10T19:32Z [----] followers, [----] engagements

"$PSNL short interest increased to 7.18M shares while we patiently wait for reimbursement. Meanwhile @GoldmanSachs: "Investors should keep in mind the potential convexity of low-quality stocks to the upside in a scenario where the macroeconomic outlook is more positive than feared such as a soft CPI print." And/or reimbursement.🙃 Got this completely backward at first. Turns out with seemingly everyone and their mother short the Russell [----] $PSNL's short interest surged following its inclusion. By the end of June over [---] million shares were sold short roughly 7% of all outstanding shares."
X Link 2025-08-12T17:14Z [----] followers, 19.2K engagements

"Institutional ownership in $PSNL is at an all-time high. Out of 88.7M shares outstanding institutions hold 69.9M shares (70M including mine🙃) leaving just 18.8M shares (21%) in the public float. With 7.1M shares sold short thats a significant risk for shorts given the limited supply"
X Link 2025-08-20T09:44Z [----] followers, [----] engagements

"Biotech is looking riper than the forbidden fruit. 🍎"
X Link 2025-08-24T16:42Z [----] followers, [----] engagements

"Data from the end of [----] showed that 86% of CIOs planned to move some public cloud workloads back to private cloud or on-premises. The highest on record for the Barclays CIO Survey. $GTLB: "We're the only software provider in this category that allows customers to run the software on-premise in air-gapped environments""
X Link 2025-09-02T09:21Z [----] followers, [----] engagements

"Per the latest reading (08/29/2025) $PSNL shorts increased their position by another 8% bringing the total to 8.15M shares. Personally I dont think thats a great idea. 🙃 $PSNL short interest increased to 7.18M shares while we patiently wait for reimbursement. Meanwhile @GoldmanSachs: "Investors should keep in mind the potential convexity of low-quality stocks to the upside in a scenario where the macroeconomic outlook is more positive than https://t.co/MGYx5Z9BiD $PSNL short interest increased to 7.18M shares while we patiently wait for reimbursement. Meanwhile @GoldmanSachs: "Investors"
X Link 2025-09-11T16:08Z [----] followers, [----] engagements

"Relatively speaking biotech has still so much room to run. $ARKG / $ARKK / $ARKW Over the past [---] years Ive built a concentrated biotech portfolio now valued at over $1000000. I plan to hold and actively manage it through the coming biotech bull market which I believe is about to ignite. My largest positions are $PSNL / $LAB / $PRME. Cowboys may come https://t.co/TjZdbv6vaI Over the past [---] years Ive built a concentrated biotech portfolio now valued at over $1000000. I plan to hold and actively manage it through the coming biotech bull market which I believe is about to ignite. My largest"
X Link 2025-09-11T19:52Z [----] followers, 51.9K engagements

"Totally second this sentiment by @verdadcap: "Biotech is where I'm spending most of my time because I think it's so interesting. The biotech market has just been annihilated like absolutely shellacked. I'm sure most of the concentrated dedicated Biotech funds are massively shrunk if not going out of business. It's probably the biggest place of pain in the small-cap equity market right now. My sort of intuition is that we're going through a period of biotechnological advances that probably is similar to Florence and the Renaissance. This is like a moment in history where we're making massive"
X Link 2025-09-14T11:03Z [----] followers, 75.2K engagements

"If youre short Biotech pivot to being long Biotech.🙃 $XBI / $ARKG Feels squeezy out there. $XBI 🍋🍋🍋 Feels squeezy out there. $XBI 🍋🍋🍋"
X Link 2025-09-16T17:16Z [----] followers, [----] engagements

"@profplum99 Is it the ghost of the HMS Vanguard that haunts us"
X Link 2025-09-22T18:06Z [----] followers, [----] engagements

"Built a $SOC position over the past few days. x = $18. The spice must flow"
X Link 2025-10-03T08:52Z [----] followers, 11.9K engagements

""In our view it is simply a matter of time before $TWST becomes a consensus long and a favorite in the Tools & Dx universe." FRFR "Twist is now developing proprietary enzymes in-house" https://t.co/usyS2mQjUT "Twist is now developing proprietary enzymes in-house" https://t.co/usyS2mQjUT"
X Link 2025-10-05T10:38Z [----] followers, 13.8K engagements

""So let me get this straight. Youre short over seven million shares of what now $PSNL You mean to tell me you bet against a high-volatility biotech stock thats now skyrocketing and you cant even cover without sending the price higher And on top of that $TEM is out there scooping up shares like theyre on sale pushing their stake to 20% bidding like crazy Oh and theres a massive catalyst coming that could completely change the game Buddy thats not a red flag thats a whole marching band of warning signs Then I hear $MRK bought 16% and the companys data looks phenomenal. So let me guess this all"
X Link 2025-10-08T17:03Z [----] followers, [----] engagements

"$PSNL above $700M market cap. Still $300M to go.🙃 $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW"
X Link 2025-10-08T17:26Z [----] followers, [----] engagements

"Ring ring ring ring ring. Margin calling $PSNL Got this completely backward at first. Turns out with seemingly everyone and their mother short the Russell [----] $PSNL's short interest surged following its inclusion. By the end of June over [---] million shares were sold short roughly 7% of all outstanding shares. Given https://t.co/PR0bZP1xI1 Got this completely backward at first. Turns out with seemingly everyone and their mother short the Russell [----] $PSNL's short interest surged following its inclusion. By the end of June over [---] million shares were sold short roughly 7% of all outstanding"
X Link 2025-10-08T19:05Z [----] followers, [----] engagements

"The spice must flow and I will see to it that no one not even this so-called prophet disrupts the balance of power. Emperor Shaddam $SOC Built a $SOC position over the past few days. x = $18. The spice must flow https://t.co/vrajZ0yjMn Built a $SOC position over the past few days. x = $18. The spice must flow https://t.co/vrajZ0yjMn"
X Link 2025-10-09T21:58Z [----] followers, [----] engagements

"$PSNL now at $900M market cap. Still $100M to go.🙃 $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW $PSNL WILL BE A BILLION DOLLAR COMPANY https://t.co/QT80dnAeNW"
X Link 2025-10-17T07:52Z [----] followers, [----] engagements

"$PSNL up 10x since Oct [----]. Exactly two years after @jpmorgan dumped their 10% stake and sent it into penny stock purgatory.🙃 Puhh $PSNL no longer a Penny Stock. Was fun but let's not do that again please. https://t.co/AiDbDX9HjY Puhh $PSNL no longer a Penny Stock. Was fun but let's not do that again please. https://t.co/AiDbDX9HjY"
X Link 2025-10-20T15:36Z [----] followers, [----] engagements

""The era of MRD emerging in NSCLC." $PSNL #ESMO25 Lung mini orals🔥 MRD analysis in LAURA trial: - tumor-informed personalis assay - 52pts assessed for MRD (osi=34 pbo=18) - BL MRD+ clearance 84% (16/19) osi 0% (0/10) pbo Interesting small n. The era of MRD emerging in NSCLC #ESMO25 #ESMOAmbassadors @myESMO https://t.co/3oaMGOi2D7 #ESMO25 Lung mini orals🔥 MRD analysis in LAURA trial: - tumor-informed personalis assay - 52pts assessed for MRD (osi=34 pbo=18) - BL MRD+ clearance 84% (16/19) osi 0% (0/10) pbo Interesting small n. The era of MRD emerging in NSCLC #ESMO25 #ESMOAmbassadors @myESMO"
X Link 2025-10-20T20:09Z [----] followers, [----] engagements

"Ill be traveling for the next [--] weeks with limited internet access. Try not to burn the place down while Im gone"
X Link 2025-10-23T14:35Z [----] followers, [---] engagements

"Don't Panic $PSNL"
X Link 2025-11-05T00:31Z [----] followers, [----] engagements

"The real price is the friends we made along the way. Congratulations to @PersonalisInc and all fellow $PSNL shareholders🙂 $PSNL money printing will start now $PSNL money printing will start now"
X Link 2025-11-10T17:57Z [----] followers, [----] engagements

"Congratulations to the $PSNL team and all fellow shareholders who have stuck with the company over the past few years. 🎉 MAJOR NEWS: Medicare now covers NeXT Personal for breast cancer surveillance This is a game-changer for doctors and patients 💗 ✅ Stage II & III breast cancer ✅ All [--] major subtypes (HR+/HER2- HER2+ TNBC) ✅ Up to [--] years of recurrence monitoring Medicare https://t.co/PpNz3CDatt 🎉 MAJOR NEWS: Medicare now covers NeXT Personal for breast cancer surveillance This is a game-changer for doctors and patients 💗 ✅ Stage II & III breast cancer ✅ All [--] major subtypes (HR+/HER2-"
X Link 2025-11-10T19:34Z [----] followers, [----] engagements

"Listen to the man $PSNL MD109 knows what's up $PSNL https://t.co/KBY9Z1vcLG MD109 knows what's up $PSNL https://t.co/KBY9Z1vcLG"
X Link 2025-11-11T16:14Z [----] followers, [----] engagements

"Analysts will be busy raising $PSNL price targets for years to come🙃 Guggenheim updates target for $PSNL: [--] [--]. HC Wainwright updates target for $PSNL: [--] [--]. BTIG updates target for $PSNL: [--] 12"
X Link 2025-11-11T16:20Z [----] followers, [---] engagements

"Im a simple man. I see China adding [---] GW of solar capacity while the U.S. adds just [--] GW in [----] and as I watch investment bank analysts foaming at the mouth about an impending energy crunch in America I immediately stop thinking and start buying $TE at an $800M market cap"
X Link 2025-11-13T08:37Z [----] followers, 50.3K engagements

"The $PSNL story for the next couple of years. Don't MidCurve it anon"
X Link 2025-11-16T21:52Z [----] followers, [----] engagements

"Great to see $PSNL continuing to innovate on its MRD platform. Real-Time variant tracking as an add-on to NeXT Personal should be incrementally positive for ASPs over the longer term as well. This functionality further differentiates the offering versus $NTRA Signatera establishing a clear and defensible competitive vector for the test. https://twitter.com/i/web/status/2011001868869104081 https://twitter.com/i/web/status/2011001868869104081"
X Link 2026-01-13T09:06Z [----] followers, [----] engagements

"Appropriate time to resurface this. $ARKG / $PSNL $ARKG short interest has increased by 10.35%. $PSNL short interest has increased by 8.24%. https://t.co/Bgxoce9pmV $ARKG short interest has increased by 10.35%. $PSNL short interest has increased by 8.24%. https://t.co/Bgxoce9pmV"
X Link 2026-01-22T15:57Z [----] followers, [----] engagements

Topic Creators

https://lunarcrush.com/api4/public/topic/:topic/creators/v1

Get the top creators for a social topic

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/topic/bitcoin/creators/v1

Example response:

{
  "data": [
    {
      "creator_id": "twitter::1605310254085980161",
      "creator_name": "Bitcoin_Teddy",
      "creator_avatar": "https://pbs.twimg.com/profile_images/1739753415134138368/FrWHMAnb_200x200.jpg",
      "creator_followers": 74293,
      "creator_rank": 1,
      "interactions_24h": [-------]
    }
  ]
}

Schema:

Creators List

https://lunarcrush.com/api4/public/creators/list/v1

Get a list of trending social creators over all of social based on interactions. To get lists of creators by category or topic see the topics and categories endpoints.

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creators/list/v1

Example response:

{
  "data": [
    {
      "creator_name": "elonmusk",
      "creator_display_name": "Elon Musk",
      "creator_id": "44196397",
      "creator_network": "twitter",
      "creator_avatar": "https://pbs.twimg.com/profile_images/2008546467615580160/57KcqsTA_200x200.jpg",
      "creator_followers": 234295750,
      "creator_posts": 3649,
      "creator_rank": 1,
      "interactions_24h": [---------]
    }
  ]
}

Schema:

Creator

https://lunarcrush.com/api4/public/creator/:network/:id/v1

Get detail information on a specific creator

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creator/twitter/elonmusk/v1

Example response:

{
  "data": {
    "creator_id": "twitter::44196397",
    "creator_name": "elonmusk",
    "creator_display_name": "Elon Musk",
    "creator_avatar": "https://pbs.twimg.com/profile_images/2008546467615580160/57KcqsTA_200x200.jpg",
    "creator_followers": 234296337,
    "creator_rank": 2,
    "interactions_24h": 318539577,
    "topic_influence": [
      {
        "topic": "in the",
        "count": 294,
        "percent": 5.88,
        "rank": [--]
      }
    ],
    "top_community": [
      {
        "creator_name": "grok",
        "creator_display_name": "Grok",
        "creator_avatar": "https://pbs.twimg.com/profile_images/1893219113717342208/Vgg2hEPa_200x200.jpg",
        "count": [---]
      }
    ]
  }
}

Schema:

Creator Time Series

https://lunarcrush.com/api4/public/creator/:network/:id/time-series/v1

Get time series data on a creator.

input parameters:

Example request:

curl -H "Authorization: Bearer <API_KEY>" https://lunarcrush.com/api4/public/creator/twitter/lunarcrush/time-series/v1

Example response:

{
  "config": {
    "network": "twitter",
    "influencer_id": "twitter::988992203568562176",
    "interval": "1w",
    "start": 1769990400,
    "end": 1770681600,
    "bucket": "hour",
    "name": "lunarcrush",
    "remote_api": "danode1-13",
    "generated": [----------]
  },
  "data": [
    {
      "time": 1769990400,
      "followers": 305326,
      "interactions": 717,
      "posts_active": 14,
      "creator_rank": [------]
    }
  ]
}

Schema:

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing